Compare stocks
Evaluate stocks side by side, to find the best fit for your investment goals.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
View stockEli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
View stockPerformance
CumulativeRolling yearsLump sum investment
Invest in $EVMN or $LLY on Lightyear
Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.